NM_001371904.1:c.162-43A>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001371904.1(APOA5):​c.162-43A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

APOA5
NM_001371904.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.540

Publications

58 publications found
Variant links:
Genes affected
APOA5 (HGNC:17288): (apolipoprotein A5) The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009]
APOA5 Gene-Disease associations (from GenCC):
  • hypertriglyceridemia 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hyperlipoproteinemia type V
    Inheritance: AD, SD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371904.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOA5
NM_001371904.1
MANE Select
c.162-43A>T
intron
N/ANP_001358833.1Q6Q788
APOA5
NM_001166598.2
c.162-43A>T
intron
N/ANP_001160070.1A0A0B4RUS7
APOA5
NM_052968.5
c.162-43A>T
intron
N/ANP_443200.2Q6Q788

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOA5
ENST00000227665.9
TSL:1 MANE Select
c.162-43A>T
intron
N/AENSP00000227665.4Q6Q788
APOA5
ENST00000433069.2
TSL:1
c.162-43A>T
intron
N/AENSP00000399701.2Q6Q788
APOA5
ENST00000673688.1
c.203A>Tp.Glu68Val
missense
Exon 3 of 3ENSP00000501141.1A0A669KB69

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
1341000
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
669708
African (AFR)
AF:
0.00
AC:
0
AN:
31078
American (AMR)
AF:
0.00
AC:
0
AN:
39434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25138
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81306
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5572
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1024740
Other (OTH)
AF:
0.00
AC:
0
AN:
56510
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.6
DANN
Benign
0.81
PhyloP100
-0.54
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072560; hg19: chr11-116661826; API